Filter Results
Related Organization
- Biological and Environmental Systems Science Directorate
(23)
- Computing and Computational Sciences Directorate (35)
- Energy Science and Technology Directorate (217)
- Fusion and Fission Energy and Science Directorate (21)
- Information Technology Services Directorate (2)
- Isotope Science and Enrichment Directorate (6)
- National Security Sciences Directorate (17)
- Neutron Sciences Directorate (11)
- Physical Sciences Directorate (128)
- User Facilities (27)
Researcher
- Mingyan Li
- Sam Hollifield
- Brian Sanders
- Brian Weber
- Bruce Moyer
- Debjani Pal
- Gerald Tuskan
- Ilenne Del Valle Kessra
- Isaac Sikkema
- Jeffrey Einkauf
- Jennifer M Pyles
- Jerry Parks
- Joseph Olatt
- Justin Griswold
- Kevin Spakes
- Kunal Mondal
- Kuntal De
- Laetitia H Delmau
- Lilian V Swann
- Luke Koch
- Luke Sadergaski
- Mahim Mathur
- Mary A Adkisson
- Mike Zach
- Oscar Martinez
- Padhraic L Mulligan
- Paul Abraham
- Sandra Davern
- T Oesch
- Vilmos Kertesz
- Xiaohan Yang
- Yang Liu

Ruthenium is recovered from used nuclear fuel in an oxidizing environment by depositing the volatile RuO4 species onto a polymeric substrate.

Detection of gene expression in plants is critical for understanding the molecular basis of plant physiology and plant responses to drought, stress, climate change, microbes, insects and other factors.

Spherical powders applied to nuclear targetry for isotope production will allow for enhanced heat transfer properties, tailored thermal conductivity and minimize time required for target fabrication and post processing.

Direct-acting antivirals are needed to combat coronavirus disease 2019 (COVID-19), which is caused by severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2).

Real-time tracking and monitoring of radioactive/nuclear materials during transportation is a critical need to ensure safety and security. Current technologies rely on simple tagging, using sensors attached to transport containers, but they have limitations.

Biocompatible nanoparticles have been developed that can trap and retain therapeutic radionuclides and their byproducts at the cancer site. This is important to maximize the therapeutic effect of this treatment and minimize associated side effects.

There is a critical need for new antiviral drugs for treating infections of severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2).